ASPIRE Study

Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery (ASPIRE)

Temporoparietal brain hemorrhage shown on an MRI scan

AGE: 18 years and older
SEX AT BIRTH: All
TYPE: Investigational Drug Study
CONDITION: Brain Hemorrhage
HEALTHY PARTICIPANTS: No
LOCATION: UH Cleveland Medical Center

Learn More About This Research Study

For more information, please contact study coordinator, Mary Andrews at 216-844-2386 and leave a message or complete the online form below.

Study Purpose

The purpose of this research study is to compare the effects of apixaban (also known as Eliquis®) with aspirin in patients with atrial fibrillation and a recent brain hemorrhage to see which is better in preventing strokes and death.

Who Can Participate

Participants 18 years and older experienced an intracerebral hemorrhage may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

XXX-XXX-XXXX

STUDY ID#